Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER THERAPY

Neoadjuvant immune-checkpoint blockade in resectable colon cancer

Nature Medicine volume 26, pages 473–474 (2020)Cite this article

Subjects

Neoadjuvant checkpoint blockade achieves deep or complete pathologic responses in patients with mismatch-repair-deficient and mismatch-repair-proficient early colon cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Neoadjuvant CTLA-4–PD-1 blockade in colon cancer.

References

  1. Le, D. T. et al. N. Engl. J. Med. 372, 2509–2520 (2015).

    Article  CAS  Google Scholar 

  2. Chalabi, M. et al. Nat. Med. https://doi.org/10.1038/s41591-020-0805-8 (2020).

  3. Wei, S. C., Duffy, C. R. & Allison, J. P. Cancer Discov. 8, 1069–1086 (2018).

    Article  Google Scholar 

  4. Tumeh, P. C. et al. Nature 515, 568–571 (2014).

    Article  CAS  Google Scholar 

  5. Thommen, D. S. et al. Nat. Med. 24, 994–1004 (2018).

    Article  CAS  Google Scholar 

  6. Fairfax, B. P. et al. Nat. Med. 26, 193–199 (2020).

    Article  CAS  Google Scholar 

  7. Yost, K. E. et al. Nat. Med. 25, 1251–1259 (2019).

    Article  CAS  Google Scholar 

  8. Siddiqui, I. et al. Immunity 50, 195–211.e10 (2019).

    Article  CAS  Google Scholar 

  9. Łuksza, M. et al. Nature 551, 517–520 (2017).

    Article  Google Scholar 

  10. Liu, J. et al. Cancer Discov. 6, 1382–1399 (2016).

    Article  CAS  Google Scholar 

  11. Pai, C. S. et al. Immunity 50, 477–492.e8 (2019).

    Article  CAS  Google Scholar 

  12. Angelova, M. et al. Cell 175, 751–765.e16 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Institute for Cancer Research, and Department of Oncology, University of Lausanne and University Hospital of Lausanne, Lausanne, Switzerland

    George Coukos

Authors
  1. George Coukos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George Coukos.

Ethics declarations

Competing interests

G.C. has received grants or research support from or is co-investigator in clinical trials by BMS, Celgene, Boehringer Ingelheim, Roche, Iovance and Kite, and has received honoraria for consultations or presentations by Roche, Genentech, BMS, AstraZeneca, Sanofi-Aventis, Nextcure and GeneosTx.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coukos, G. Neoadjuvant immune-checkpoint blockade in resectable colon cancer. Nat Med 26, 473–474 (2020). https://doi.org/10.1038/s41591-020-0826-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-020-0826-3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing